Comparison between Tc-99 m DTPA and Tc-99 m MAG3 Renal Scintigraphy for Prediction of Early Adverse Outcome After Kidney Transplantation
Tóm tắt
Renal scintigraphy (RS) with either technetium-99 m diethylene-triamine-pentaacetate (Tc-99 m DTPA) or technetium-99 m mercaptoacetyltriglycine (Tc-99 m MAG3) has both been used to evaluate early allograft function after kidney transplantation (KT). This study was done to compare the predictive performance of RS using these two radiopharmaceuticals for prediction of outcomes during first 3 months of KT. This retrospective study included patients who received KT then underwent both Tc-99 m DTPA and Tc-99 m MAG3 RS, successively. Receiver operating characteristic (ROC) curve analysis was used to determine the predictiveness of RS parameters on early clinical adverse outcomes of either (1) graft-related death, (2) need for graft resection, (3) delayed graft function requiring temporary dialysis, or (4) a serum creatinine level of ≥ 2.0 mg/dL at three months post-KT, as well as to predict biopsy-confirmed acute tubular necrosis and acute rejection. Of 187 patients included, 77 (41.2%) had at least one early adverse clinical outcome. Tc-99 m MAG3 RS was more predictive than Tc-99 m DTPA RS, in terms of AUCROC, in three parameters including time to peak (0.754 vs. 0.516, p-value 0.0001), 20-min to peak ratio (0.762 vs. 0.651, p-value 0.006), and 20-min to 3-min ratio (0.823 vs. 0.699, p-value 0.0005). Acute tubular necrosis was better predicted by Tc-99 m MAG3 RS while both were at best only modest in predicting acute rejection. Three parameters which, when obtained from Tc-99 m MAG3 RS, had superior predictiveness compared with Tc-99 m DTPA RS, including time to peak, 20-min to peak ratio, and 20-min to 3-min ratio.
Tài liệu tham khảo
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS ONE. 2016;11:e0158765.
Garcia GG, Harden P, Chapman J, World Kidney Day Steering Committee. The global role of kidney transplantation. Curr Opin Organ Transplant. 2012;17:362–7.
Thiruchelvam PTR, Willicombe M, Hakim N, Taube D, Papalois V. Renal transplantation. BMJ. 2011;343:d7300.
Taylor AT. Radionuclides in nephrourology, part 1: radiopharmaceuticals, quality control, and quantitative indices. J Nucl Med. 2014;55:608–15.
Bubeck B, Brandau W, Weber E, Kälble T, Parekh N, Georgi P. Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med. 1990;31:1285–93.
Eshima D, Taylor A. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent. Semin Nucl Med. 1992;22:61–73.
Hilson AJ, Maisey MN, Brown CB, Ogg CS, Bewick MS. Dynamic renal transplant imaging with Tc-99m DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants. J Nucl Med. 1978;19:994–1000.
Hilson AJ. The renal transplant perfusion index: where are we now? Eur J Nucl Med. 1991;18:227–8.
R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2020. https://www.R-project.org. Accessed 12 Jul 2020.
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
Wickham H. ggplot2: elegant graphics for data analysis. Springer-Verlag. 2016. https://ggplot2.tidyverse.org. Accessed 12 Jul 2020.
Dubovsky EV, Russell CD, Erbas B. Radionuclide evaluation of renal transplants. Semin Nucl Med. 1995;25:49–59.
Khor YM, Lam WWC, Wong WY, Whatt Goh AS. Role of nuclear medicine imaging in evaluation of complications following renal transplant. Proc Singap Healthc. 2015;24:233–42.
Racusen LC, Bagnasco SM. Peritubular capillaritis in the renal allograft takes center stage. Kidney Int. 2015;88:218–20.
Johnston O, O’kelly P, Spencer S, Donohoe J, Walshe JJ, Little DM, et al. Reduced graft function (with or without dialysis) vs immediate graft function–a comparison of long-term renal allograft survival. Nephrol Dial Transpl. 2006;21:2270–4.
Aitken E, Cooper C, Dempster N, McDermott M, Ceresa C, Kingsmore D. Delayed graft function is a syndrome rather than a diagnosis. Exp Clin Transpl. 2015;13:19–25.
Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). Am J Roentgenol. 1982;138:565–70.
Fine EJ, Axelrod M, Gorkin J, Saleemi K, Blaufox MD. Measurement of effective renal plasma flow: a comparison of methods. J Nucl Med. 1987;28:1393–400.
Carmody E, Greene A, Brennan P, Donohue J, Carmody M, Keeling F. Sequential Tc 99m mercaptoacetyl-triglycine (MAG3) renography as an evaluator of early renal transplant function. Clin Transplant. 1993;7:245–9.
Aktas A, Demirag A, Moray G, Karakayali H, Haberal M. Comparison of the scintigraphically determined function of the transplanted kidney before and after transplantation. Transplant Proc. 1999;31:3324–5.
Gupta SK, Lewis G, Rogers K, Attia J. Quantitative Tc-99m DTPA renal transplant scintigraphy predicts graft survival in the very early postoperative period. Nucl Med Commun. 2012;33:1292–9.
Aktaş A, Aras M, Colak T, Gençoğlu A, Karakayali H. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction. Transplant Proc. 2006;38:449–53.
Wu WK, Famure O, Li Y, Kim SJ. Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation. Kidney Int. 2015;88:851–8.
Melih KV, Boynuegri B, Mustafa C, Nilgun A. Incidence, risk factors, and outcomes of delayed graft function in deceased donor kidney transplantation. Transplant Proc. 2019;51:1096–100.